反応 #5779

ord-28eff96ac1a74bc0827f6036314dc85e

反応方程式

Cl
hydrochloric acid
[Cl-].[Cl-].[Mg+2]
magnesium chloride
CCN(C(C)C)C(C)C
diisopropylethylamine
O=C1O[C@H]([C@@H](O)CO)C(O)=C1O
ascorbic acid
CC(C)(C)C(C(=O)O)C(=O)O
1,1-dimethylethyl malonic acid
[K]
potassium
O=C1O[C@H]([C@H](O)CO)C(O)=C1O
isoascorbic acid
CC(C)(C)[Si](C)(C)O[C@H](CC#N)CC(=O)O
(R)-4-cyano-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]butanoic acid
O=C(n1ccnc1)n1ccnc1
carbonyldiimidazole
CC(C)(C)C(C(=O)O)C(=O)O
1,1-dimethylethyl malonic acid
CC(C)(C)OC(=O)CC(=O)C[C@@H](CC#N)O[Si](C)(C)C(C)(C)C
(R)-1,1-dimethylethyl 6-cyano-5-[(1,1-dimethylethyl)dimethylsilyl]oxy-3-oxohexanoate

反応条件

温度
25°CELSIUS
詳細条件
See reaction.notes.procedure_details.

後処理

  1. 1
    その他the activated acid derivative is not isolated
  2. 2
    その他at -10° C. to 20° C.
  3. 3
    その他preferably at 5° C

実験手順

Thus, the optically active compounds are prepared from the known isoascorbic acid using the methodology described by Volante R. P. et al., in U.S. Pat. No. 4,611,067 but in that case starting with ascorbic acid. This establishes the optically active centers desired in Formula XXVa and Formula XXIIIa as R. Thus, the (R)-4-cyano-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]butanoic acid of Formula XXIX is treated with carbonyldiimidazole in tetrahydrofuran at 0° C. to -40° C., preferably -20° C., warmed to 25° C. and the activated acid derivative is not isolated but the solution is added to a suspension of a salt of 1,1-dimethylethyl malonic acid such as, for example, the potassium salt of 1,1-dimethylethyl malonic acid (half ester, half salt) anhydrous magnesium chloride, and an amine such as, for example, diisopropylethylamine in acetonitrile at -10° C. to 20° C. preferably at 5° C. The mixture is poured into a mixture of 1N hydrochloric acid and ethyl acetate to afford the (R)-1,1-dimethylethyl 6-cyano-5-[(1,1-dimethylethyl)dimethylsilyl]oxy-3-oxohexanoate of Formula XXVIII. The ketone of Formula XXVIII is treated with fluoride ion at 0° C. to 65° C., preferably 25° C. to afford the (R)-1,1-dimethylethyl 6-cyano-5-hydroxy-3-oxo-hexanoate of Formula XXVII. The ketone of Formula XXVII is treated with triethylborane and air (or methoxydiethylborane without air) followed by sodium borohydride and methanol in tetrahydrofruan at -78° C. to -110° C., preferably -100° C. to afford [R-(R*,R*)]-1,1-dimethylethyl 6-cyano-3,5-hydroxyhexanoate of Formula XXVI. The diol of Formula XXVI is treated with a ketal forming reagent as such as, for example, acetone, dimethoxypropane, 2-methoxypropene, benzaldehyde, cyclopentanone, cyclohexanone, 1,1-dimethoxycyclopentane, 1,1-dimethoxycyclohexane and the like, in the presence of an acid such as, for example, camphorsulfonic acid, para-toluenesulfonic acid, and the like, in the presence of excess reagent or in an inert solvent such as, for example, dichloromethane, and the like, at 0° C. to the reflux temperature of the reagent or solvent to afford a compound of Formula XXVa wherein R7 and R8 are independently hydrogen, alkyl of from one to three carbon atoms, phenyl or R7 and R8 are taken together as --(CH2)n --, wherein n is 4 or 5.

出典

DOI: 10.6084/m9.figshare.5104873.v1特許: US05245047uspto-grants-1993_09